23 Jan ZoBio Sells to Oncodesign Services
BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services. ZoBio is a leading provider of biophysics-based small molecule drug discovery services.The full press release is below.Dijon, France & Leiden, The Netherlands, January 23rd, 2024 – Oncodesign Services (ODS), a leading...
Stay connected
Partner with BroadOak